Applied Dna Sciences Inc financial data

Symbol
APDN on Nasdaq, APPDW on OTC
Industry
Services-Testing Laboratories
Location
50 Health Sciences Drive, Stony Brook, NY
State of incorporation
Delaware
Fiscal year end
September 30
Former names
PROHEALTH MEDICAL TECHNOLOGIES INC (to 12/18/2002), DCC ACQUISITION CORP (to 5/4/2001), DATALINK CAPITAL CORP/TX/ (to 2/8/1999)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 261 % -44.3%
Quick Ratio 13.7 % +11.5%
Debt-to-equity 132 % +35.4%
Return On Equity -138 % -93.4%
Return On Assets -59 % -62.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.3M shares -24.6%
Common Stock, Shares, Outstanding 10.3M shares -20.2%
Entity Public Float 14.4M USD -16.3%
Common Stock, Value, Issued 10.3K USD -20.2%
Weighted Average Number of Shares Outstanding, Basic 4.01M shares +522%
Weighted Average Number of Shares Outstanding, Diluted 4.01M shares +522%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 2.55M USD -75.2%
Research and Development Expense 3.7M USD -0.22%
Operating Income (Loss) -14.9M USD -35.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.39M USD -4.5%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -7.29M USD -3.85%
Earnings Per Share, Basic -1.5 USD/shares +63.7%
Earnings Per Share, Diluted -1.5 USD/shares +65%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.4M USD -2.92%
Accounts Receivable, after Allowance for Credit Loss, Current 514K USD -24.7%
Inventory, Net 470K USD +70%
Assets, Current 11.8M USD -3.25%
Property, Plant and Equipment, Net 531K USD -54.6%
Operating Lease, Right-of-Use Asset 868K USD -36%
Intangible Assets, Net (Excluding Goodwill) 2.7M USD
Assets 16.7M USD +5.7%
Accounts Payable, Current 1.6M USD +52%
Contract with Customer, Liability, Current 51.3K USD -81.4%
Liabilities, Current 3.03M USD +4.65%
Contract with Customer, Liability, Noncurrent 194K USD
Deferred Income Tax Liabilities, Net 684K USD
Operating Lease, Liability, Noncurrent 334K USD -61.5%
Liabilities 4.46M USD -48.2%
Retained Earnings (Accumulated Deficit) -306M USD -2.52%
Stockholders' Equity Attributable to Parent 12.4M USD +70.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 12.2M USD +70.1%
Liabilities and Equity 16.7M USD +5.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.76M USD -57.7%
Net Cash Provided by (Used in) Financing Activities -35.1K USD
Net Cash Provided by (Used in) Investing Activities 45K USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 10.3M shares -20.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.79M USD -62.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.2M USD -2.73%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 31M USD +17.1%
Deferred Tax Assets, Gross 31.4M USD +18.4%
Operating Lease, Liability 1.24M USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.37M USD
Property, Plant and Equipment, Gross 4.25M USD -0.99%
Operating Lease, Liability, Current 534K USD +9.49%
Lessee, Operating Lease, Liability, to be Paid, Year Two 586K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 586K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 130K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 195K USD
Deferred Tax Assets, Operating Loss Carryforwards 25.3M USD +10.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 299K USD -11.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%